Disease-Specific Deep Dives

Focused discussions on the biological and therapeutic nuances of specific malignancies, including breast cancer, lung cancer, gastrointestinal cancers, and hematological malignancies.
Articles analyze evidence-based treatment approaches, biomarker relevance, emerging therapies, and clinical decision-making frameworks for individual cancer types

Healthy and 40+: Which Breast Screening Do You Actually Need?

Series: Well Woman ConversationsBy: Dr Raman Narang, Consultant Medical & Hemato-OncologistLast reviewed: September 2026 The direct answer If you are 40 or older, have

Disease-Specific Deep Dives

Molecular Subtypes of Breast Cancer and Their Treatment Implications

Dr Raman Narang / February 28, 2026 / Disease-Specific Deep Dives / brca, breast cancer, ER/PR, Her2, molecular subtypes

Molecular subtypes of Breast cancer is biologically classified using ER, PR, and HER2 status (and sometimes proliferation/genomic assays). These markers

Disease-Specific Deep Dives

Molecular Subtypes Across Common Cancers: Why Biology Matters More Than Stage

Dr Raman Narang / February 26, 2026 / Disease-Specific Deep Dives / biology vs stage in cancer, cancer biomarker testing, molecular subtypes in cancer, precision oncology treatment, targeted therapy decision making

Cancer stage describes where the disease has spread. Molecular subtypes in cancer explains how the cancer behaves. In modern oncology,